06:04:07 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-07-31 Kvartalsrapport 2024-Q2
2024-06-13 Ordinarie utdelning CAV1V 0.00 EUR
2024-06-12 Årsstämma 2024
2024-02-08 Bokslutskommuniké 2023
2023-11-15 Extra Bolagsstämma 2023
2023-11-03 Kvartalsrapport 2023-Q3
2023-08-03 Kvartalsrapport 2023-Q2
2023-04-27 Kvartalsrapport 2023-Q1
2023-03-28 Ordinarie utdelning CAV1V 0.20 EUR
2023-03-27 Årsstämma 2023
2023-02-09 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-04 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-03-29 Ordinarie utdelning CAV1V 0.17 EUR
2022-03-28 Årsstämma 2022
2022-02-10 Bokslutskommuniké 2021
2021-11-04 Kvartalsrapport 2021-Q3
2021-08-05 Kvartalsrapport 2021-Q2
2021-04-29 Kvartalsrapport 2021-Q1
2021-03-25 Ordinarie utdelning CAV1V 0.10 EUR
2021-03-25 Bonusutdelning CAV1V 0.1
2021-03-24 Årsstämma 2021
2021-02-11 Bokslutskommuniké 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-08-06 Kvartalsrapport 2020-Q2
2020-05-26 Ordinarie utdelning CAV1V 0.00 EUR
2020-05-25 Årsstämma 2020
2020-04-30 Kvartalsrapport 2020-Q1
2020-02-07 Bokslutskommuniké 2019
2019-10-29 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-26 Ordinarie utdelning CAV1V 0.05 EUR
2019-03-25 Årsstämma 2019
2019-02-05 Bokslutskommuniké 2018
2018-10-25 Kvartalsrapport 2018-Q3
2018-07-25 Kvartalsrapport 2018-Q2
2018-04-24 Kvartalsrapport 2018-Q1
2018-03-27 Ordinarie utdelning CAV1V 0.00 EUR
2018-03-26 Årsstämma 2018
2018-02-07 Bokslutskommuniké 2017
2017-10-27 Kvartalsrapport 2017-Q3
2017-07-20 Kvartalsrapport 2017-Q2
2017-04-28 Kvartalsrapport 2017-Q1
2017-03-20 Ordinarie utdelning CAV1V 0.00 EUR
2017-03-17 Årsstämma 2017
2016-10-27 Kvartalsrapport 2016-Q3
2016-07-21 Kvartalsrapport 2016-Q2
2016-04-28 Kvartalsrapport 2016-Q1
2016-03-22 Ordinarie utdelning CAV1V 0.28 EUR
2016-03-21 Årsstämma 2016
2016-01-27 Bokslutskommuniké 2015
2015-10-23 Kvartalsrapport 2015-Q3
2015-09-09 Kapitalmarknadsdag 2015
2015-07-23 Kvartalsrapport 2015-Q2
2015-04-24 Kvartalsrapport 2015-Q1
2015-03-17 Ordinarie utdelning CAV1V 0.22 EUR
2015-03-16 Årsstämma 2015
2015-01-29 Bokslutskommuniké 2014
2014-10-31 Kvartalsrapport 2014-Q3
2014-09-10 Kapitalmarknadsdag 2014
2014-07-22 Kvartalsrapport 2014-Q2
2014-04-24 Kvartalsrapport 2014-Q1
2014-03-18 Ordinarie utdelning CAV1V 0.22 EUR
2014-03-17 Årsstämma 2014
2014-01-28 Bokslutskommuniké 2013
2013-11-19 Kapitalmarknadsdag 2013
2013-11-01 Kvartalsrapport 2013-Q3
2013-07-26 Kvartalsrapport 2013-Q2

Beskrivning

LandFinland
ListaMid Cap Helsinki
SektorTjänster
IndustriIndustri
Caverion är verksamma inom IT-sektorn. Bolagets specialistkompetens återfinns inom projektledning, design och konstruktion, samt tekniskt underhåll inom VVS, el - och skyddslösningar. Verksamheten är främst inriktad mot den europeiska marknaden, med störst andel kunder inom bygg- och industrisektorn. Bolaget har sitt huvudkontor i Finland.
2019-12-05 10:15:00

Caverion Corporation Investor news 5 December at 11.15 a.m. EET

Caverion wins a building technology project for the Berlin University of Medicine in Germany

A former operation theatre building at the Charité, Berlin University of Medicine in Germany will be converted into a modern research building which will be used as an outpatient and translational research and innovation centre. For the project, Caverion will implement the technical installations related to Automation, Cooling, Security and Safety, Ventilation and Air Conditioning, Heating and Sanitation, and Electricity. The Charité is one of the largest university hospitals in Europe and it is wholly-owned by the Federal State of Berlin. The value of the project is not disclosed.

[Illustration Heinle Wischer und Partner Freie Architekten]

"There are high demands of technical design in clinical environments when it comes to the well-being of patients and the indoor climate of medical and biological laboratories. During the conversion of the former operation theatre building, the focus is on ventilation technology. High-performance ventilation systems will be installed for the new research laboratories and operation theatres, which will, on completion, circulate approximately 220,000 cubic metres of air per hour," says Frank Krause, Executive Vice President, Caverion Germany.

Caverion is also going to install smoke extraction systems for technical exhaust air and will be responsible for the technology that supplies the premises with technical gases such as oxygen, carbon dioxide and nitrogen. The building will also be equipped with new heating and cooling systems and a high-pressure water mist system for fire protection.

The University Hospital will use the building as a central research building for biomedical basic research and clinical research. Seven floors will house laboratories, operating theatres, teaching areas, a data centre and patient treatment areas on a gross floor area of about 30,800 square metres.

The Charité - Universitätsmedizin Berlin represents Caverion's public sector customers. Read more about our services to the public sector (https://www.caverion.com/client-segments/public).

Illustration: © Heinle, Wischer und Partner. Freie Architekten